1 Introduction to Research & Analysis Reports
1.1 Blue Eye Disease Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blue Eye Disease Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blue Eye Disease Vaccines Overall Market Size
2.1 Global Blue Eye Disease Vaccines Market Size: 2022 VS 2029
2.2 Global Blue Eye Disease Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blue Eye Disease Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Blue Eye Disease Vaccines Players in Global Market
3.2 Top Global Blue Eye Disease Vaccines Companies Ranked by Revenue
3.3 Global Blue Eye Disease Vaccines Revenue by Companies
3.4 Global Blue Eye Disease Vaccines Sales by Companies
3.5 Global Blue Eye Disease Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blue Eye Disease Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blue Eye Disease Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blue Eye Disease Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Blue Eye Disease Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Blue Eye Disease Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Blue Eye Disease Vaccines Market Size Markets, 2022 & 2029
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type – Global Blue Eye Disease Vaccines Revenue & Forecasts
4.2.1 By Type – Global Blue Eye Disease Vaccines Revenue, 2018-2023
4.2.2 By Type – Global Blue Eye Disease Vaccines Revenue, 2024-2029
4.2.3 By Type – Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
4.3 By Type – Global Blue Eye Disease Vaccines Sales & Forecasts
4.3.1 By Type – Global Blue Eye Disease Vaccines Sales, 2018-2023
4.3.2 By Type – Global Blue Eye Disease Vaccines Sales, 2024-2029
4.3.3 By Type – Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
4.4 By Type – Global Blue Eye Disease Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blue Eye Disease Vaccines Market Size, 2022 & 2029
5.1.2 Piglets
5.1.3 Adult Pigs
5.2 By Application – Global Blue Eye Disease Vaccines Revenue & Forecasts
5.2.1 By Application – Global Blue Eye Disease Vaccines Revenue, 2018-2023
5.2.2 By Application – Global Blue Eye Disease Vaccines Revenue, 2024-2029
5.2.3 By Application – Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
5.3 By Application – Global Blue Eye Disease Vaccines Sales & Forecasts
5.3.1 By Application – Global Blue Eye Disease Vaccines Sales, 2018-2023
5.3.2 By Application – Global Blue Eye Disease Vaccines Sales, 2024-2029
5.3.3 By Application – Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
5.4 By Application – Global Blue Eye Disease Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Blue Eye Disease Vaccines Market Size, 2022 & 2029
6.2 By Region – Global Blue Eye Disease Vaccines Revenue & Forecasts
6.2.1 By Region – Global Blue Eye Disease Vaccines Revenue, 2018-2023
6.2.2 By Region – Global Blue Eye Disease Vaccines Revenue, 2024-2029
6.2.3 By Region – Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
6.3 By Region – Global Blue Eye Disease Vaccines Sales & Forecasts
6.3.1 By Region – Global Blue Eye Disease Vaccines Sales, 2018-2023
6.3.2 By Region – Global Blue Eye Disease Vaccines Sales, 2024-2029
6.3.3 By Region – Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Blue Eye Disease Vaccines Revenue, 2018-2029
6.4.2 By Country – North America Blue Eye Disease Vaccines Sales, 2018-2029
6.4.3 US Blue Eye Disease Vaccines Market Size, 2018-2029
6.4.4 Canada Blue Eye Disease Vaccines Market Size, 2018-2029
6.4.5 Mexico Blue Eye Disease Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Blue Eye Disease Vaccines Revenue, 2018-2029
6.5.2 By Country – Europe Blue Eye Disease Vaccines Sales, 2018-2029
6.5.3 Germany Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.4 France Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.5 U.K. Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.6 Italy Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.7 Russia Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.9 Benelux Blue Eye Disease Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Blue Eye Disease Vaccines Revenue, 2018-2029
6.6.2 By Region – Asia Blue Eye Disease Vaccines Sales, 2018-2029
6.6.3 China Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.4 Japan Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.5 South Korea Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.7 India Blue Eye Disease Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Blue Eye Disease Vaccines Revenue, 2018-2029
6.7.2 By Country – South America Blue Eye Disease Vaccines Sales, 2018-2029
6.7.3 Brazil Blue Eye Disease Vaccines Market Size, 2018-2029
6.7.4 Argentina Blue Eye Disease Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Blue Eye Disease Vaccines Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Blue Eye Disease Vaccines Sales, 2018-2029
6.8.3 Turkey Blue Eye Disease Vaccines Market Size, 2018-2029
6.8.4 Israel Blue Eye Disease Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Blue Eye Disease Vaccines Market Size, 2018-2029
6.8.6 UAE Blue Eye Disease Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CAHIC
7.1.1 CAHIC Company Summary
7.1.2 CAHIC Business Overview
7.1.3 CAHIC Blue Eye Disease Vaccines Major Product Offerings
7.1.4 CAHIC Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 CAHIC Key News & Latest Developments
7.2 Merial
7.2.1 Merial Company Summary
7.2.2 Merial Business Overview
7.2.3 Merial Blue Eye Disease Vaccines Major Product Offerings
7.2.4 Merial Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merial Key News & Latest Developments
7.3 MSD Animal Health
7.3.1 MSD Animal Health Company Summary
7.3.2 MSD Animal Health Business Overview
7.3.3 MSD Animal Health Blue Eye Disease Vaccines Major Product Offerings
7.3.4 MSD Animal Health Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 MSD Animal Health Key News & Latest Developments
7.4 Chopper Biology
7.4.1 Chopper Biology Company Summary
7.4.2 Chopper Biology Business Overview
7.4.3 Chopper Biology Blue Eye Disease Vaccines Major Product Offerings
7.4.4 Chopper Biology Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Chopper Biology Key News & Latest Developments
7.5 Ceva
7.5.1 Ceva Company Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Blue Eye Disease Vaccines Major Product Offerings
7.5.4 Ceva Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Ceva Key News & Latest Developments
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond Company Summary
7.6.2 ChengDu Tecbond Business Overview
7.6.3 ChengDu Tecbond Blue Eye Disease Vaccines Major Product Offerings
7.6.4 ChengDu Tecbond Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 ChengDu Tecbond Key News & Latest Developments
7.7 Veterinary
7.7.1 Veterinary Company Summary
7.7.2 Veterinary Business Overview
7.7.3 Veterinary Blue Eye Disease Vaccines Major Product Offerings
7.7.4 Veterinary Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Veterinary Key News & Latest Developments
7.8 Ringpu Biology
7.8.1 Ringpu Biology Company Summary
7.8.2 Ringpu Biology Business Overview
7.8.3 Ringpu Biology Blue Eye Disease Vaccines Major Product Offerings
7.8.4 Ringpu Biology Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Ringpu Biology Key News & Latest Developments
7.9 Qilu Animal
7.9.1 Qilu Animal Company Summary
7.9.2 Qilu Animal Business Overview
7.9.3 Qilu Animal Blue Eye Disease Vaccines Major Product Offerings
7.9.4 Qilu Animal Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Qilu Animal Key News & Latest Developments
7.10 DHN
7.10.1 DHN Company Summary
7.10.2 DHN Business Overview
7.10.3 DHN Blue Eye Disease Vaccines Major Product Offerings
7.10.4 DHN Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 DHN Key News & Latest Developments
8 Global Blue Eye Disease Vaccines Production Capacity, Analysis
8.1 Global Blue Eye Disease Vaccines Production Capacity, 2018-2029
8.2 Blue Eye Disease Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Blue Eye Disease Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blue Eye Disease Vaccines Supply Chain Analysis
10.1 Blue Eye Disease Vaccines Industry Value Chain
10.2 Blue Eye Disease Vaccines Upstream Market
10.3 Blue Eye Disease Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blue Eye Disease Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のブルーアイ症候群ワクチン市場予測2023-2029：生ワクチン、死菌ワクチン |
| 【英語タイトル】Blue Eye Disease Vaccines Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5728 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：71 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のブルーアイ症候群ワクチン市場規模と予測を収録しています。・世界のブルーアイ症候群ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のブルーアイ症候群ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のブルーアイ症候群ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ブルーアイ症候群ワクチンのグローバル主要企業は、CAHIC、 Merial、 MSD Animal Health、 Chopper Biology、 Ceva、 ChengDu Tecbond、 Veterinary、 Ringpu Biology、 Qilu Animal、 DHNなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ブルーアイ症候群ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のブルーアイ症候群ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のブルーアイ症候群ワクチン市場：タイプ別市場シェア、2022年 ・生ワクチン、死菌ワクチン 世界のブルーアイ症候群ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のブルーアイ症候群ワクチン市場：用途別市場シェア、2022年 ・子豚、成豚 世界のブルーアイ症候群ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のブルーアイ症候群ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるブルーアイ症候群ワクチンのグローバル売上、2018年-2023年 ・主要企業におけるブルーアイ症候群ワクチンのグローバル売上シェア、2022年 ・主要企業におけるブルーアイ症候群ワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるブルーアイ症候群ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 CAHIC、 Merial、 MSD Animal Health、 Chopper Biology、 Ceva、 ChengDu Tecbond、 Veterinary、 Ringpu Biology、 Qilu Animal、 DHN ************************************************************* ・調査・分析レポートの概要 ブルーアイ症候群ワクチン市場の定義 市場セグメント 世界のブルーアイ症候群ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のブルーアイ症候群ワクチン市場規模 世界のブルーアイ症候群ワクチン市場規模：2022年 VS 2029年 世界のブルーアイ症候群ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのブルーアイ症候群ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のブルーアイ症候群ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：生ワクチン、死菌ワクチン ブルーアイ症候群ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：子豚、成豚 ブルーアイ症候群ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別ブルーアイ症候群ワクチン市場規模 2022年と2029年 地域別ブルーアイ症候群ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） CAHIC、 Merial、 MSD Animal Health、 Chopper Biology、 Ceva、 ChengDu Tecbond、 Veterinary、 Ringpu Biology、 Qilu Animal、 DHN ... |
PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs
This report aims to provide a comprehensive presentation of the global market for Blue Eye Disease Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Eye Disease Vaccines. This report contains market size and forecasts of Blue Eye Disease Vaccines in global, including the following market information:
Global Blue Eye Disease Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Blue Eye Disease Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Blue Eye Disease Vaccines companies in 2022 (%)
The global Blue Eye Disease Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blue Eye Disease Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blue Eye Disease Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blue Eye Disease Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blue Eye Disease Vaccines Market Segment Percentages, by Type, 2022 (%)
Live Vaccines
Killed Vaccines
Global Blue Eye Disease Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blue Eye Disease Vaccines Market Segment Percentages, by Application, 2022 (%)
Piglets
Adult Pigs
Global Blue Eye Disease Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blue Eye Disease Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blue Eye Disease Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blue Eye Disease Vaccines revenues share in global market, 2022 (%)
Key companies Blue Eye Disease Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Blue Eye Disease Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blue Eye Disease Vaccines, market overview.
Chapter 2: Global Blue Eye Disease Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blue Eye Disease Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blue Eye Disease Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のブルーアイ症候群ワクチン市場予測2023-2029：生ワクチン、死菌ワクチン] (コード：MMG23JU5728)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のブルーアイ症候群ワクチン市場予測2023-2029：生ワクチン、死菌ワクチン]についてメールでお問い合わせ |
